Inside CMS - 01/09/2020

With H.R. 3’s CBO Score, Medigap Protections More Viable Policy Option

By Michelle M. Stein / January 3, 2020 at 12:23 PM
Beneficiary advocates are pleased that House Speaker Nancy Pelosi’s (D-CA) drug pricing bill passed the lower chamber with a number of Medicare improvements, including protections aimed at expanding the number of beneficiaries who can access a Medigap plan. Even though Pelosi’s bill is expected to stall in the Senate, some following the issue say the package’s inclusion of the Medigap policies has spurred dialogue on the issue and the policies could be on the table for future health care legislation...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.